Clinical Trial

Brain Ultrafast Ultrasound Imaging

Study acronym: Brain Ultrafas
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Congenital heart defects affect 1 in 100 births in France, with rising prevalence due to better care. Despite improved survival, 40% of children post-surgery face neurological impairments, and some of them show brain lesions. Causes include heart defects, genetic syndromes, and surgeries. Some heart defects and support systems increase cerebral risks. Monitoring cerebral perfusion is difficult to assess but emerging ultrafast ultrasound offers real-time, non-invasive blood flow insights.
Trial Details
NCT Number NCT07299721
Lead Sponsor University Hospital, Bordeaux
Conditions CHD - Congenital Heart Disease
Enrollment 300 participants
Start Date 2026-01-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-23